- Home
- Publications
- Publication Search
- Publication Details
Title
Advances and Hurdles in CAR T Cell Immune Therapy for Solid Tumors
Authors
Keywords
-
Journal
Cancers
Volume 14, Issue 20, Pages 5108
Publisher
MDPI AG
Online
2022-10-19
DOI
10.3390/cancers14205108
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting Cancer-Associated Fibroblasts in the Bone Marrow Prevents Resistance to CART-Cell Therapy in Multiple Myeloma
- (2022) Reona Sakemura et al. BLOOD
- GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas
- (2022) Robbie G. Majzner et al. NATURE
- Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletion
- (2022) Leila Amini et al. Nature Reviews Clinical Oncology
- CAR-T cell-mediated depletion of immunosuppressive tumor-associated macrophages promotes endogenous antitumor immunity and augments adoptive immunotherapy
- (2021) Alba Rodriguez-Garcia et al. Nature Communications
- Chemokine Receptor CCR2b Enhanced Anti-tumor Function of Chimeric Antigen Receptor T Cells Targeting Mesothelin in a Non-small-cell Lung Carcinoma Model
- (2021) Yanan Wang et al. Frontiers in Immunology
- Befriending the Hostile Tumor Microenvironment in CAR T-Cell Therapy
- (2021) Lorenzo Lindo et al. Frontiers in Immunology
- Meningeal lymphatics affect microglia responses and anti-Aβ immunotherapy
- (2021) Sandro Da Mesquita et al. NATURE
- Case Report: Prolonged Survival Following EGFRvIII CAR T Cell Treatment for Recurrent Glioblastoma
- (2021) Joseph S. Durgin et al. Frontiers in Oncology
- CAR T-cell therapy for solid tumours
- (2021) The Lancet Oncology LANCET ONCOLOGY
- Locoregional infusion of HER2-specific CAR T cells in children and young adults with recurrent or refractory CNS tumors: an interim analysis
- (2021) Nicholas A. Vitanza et al. NATURE MEDICINE
- A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti-PD-1 agent pembrolizumab
- (2021) Prasad S Adusumilli et al. Cancer Discovery
- High-Affinity Chimeric Antigen Receptor With Cross-Reactive scFv to Clinically Relevant EGFR Oncogenic Isoforms
- (2021) Radhika Thokala et al. Frontiers in Oncology
- First-in-Human Trial of EphA2-Redirected CAR T-Cells in Patients With Recurrent Glioblastoma: A Preliminary Report of Three Cases at the Starting Dose
- (2021) Qingtang Lin et al. Frontiers in Oncology
- Using chimeric antigen receptor T-cell therapy to fight glioblastoma multiforme: past, present and future developments
- (2021) David C. Soler et al. JOURNAL OF NEURO-ONCOLOGY
- Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives
- (2021) Xiaoqi Mao et al. Molecular Cancer
- ecDNA hubs drive cooperative intermolecular oncogene expression
- (2021) King L. Hung et al. NATURE
- Improved Immunotherapy Efficacy by Vascular Modulation
- (2021) Emma L. Newport et al. Cancers
- Convection-enhanced delivery for high-grade glioma
- (2021) Jennifer H Kang et al. Neuro-Oncology Practice
- CAR T cells and checkpoint inhibition for the treatment of glioblastoma
- (2020) Steven H. Shen et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- VEGF-C-driven lymphatic drainage enables immunosurveillance of brain tumours
- (2020) Eric Song et al. NATURE
- Chimeric Antigen Receptor-Glypican-3 T-Cell Therapy for Advanced Hepatocellular Carcinoma: Results of Phase 1 Trials
- (2020) Donghua Shi et al. CLINICAL CANCER RESEARCH
- Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors
- (2020) Johanna Theruvath et al. NATURE MEDICINE
- Combined antitumor effects of anti-EGFR variant III CAR-T cell therapy and PD-1 checkpoint blockade on glioblastoma in mouse model
- (2020) Yujie Song et al. CELLULAR IMMUNOLOGY
- Anti-EGFR chimeric antigen receptor-modified T cells in metastatic pancreatic carcinoma: A phase I clinical trial
- (2020) Yang Liu et al. CYTOTHERAPY
- Mouse Tumor Models for Advanced Cancer Immunotherapy
- (2020) Daria S. Chulpanova et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Immune suppression in gliomas
- (2020) Matthew M. Grabowski et al. JOURNAL OF NEURO-ONCOLOGY
- A rational mouse model to detect on-target, off-tumor CAR T cell toxicity
- (2020) Mauro Castellarin et al. JCI Insight
- Osteosarcoma: A comprehensive review of management and treatment strategies
- (2020) Farzaneh Jafari et al. Annals of Diagnostic Pathology
- Dissecting the immunosuppressive tumor microenvironments in Glioblastoma-on-a-Chip for optimized PD-1 immunotherapy
- (2020) Xin Cui et al. eLife
- Cytokines in oncolytic virotherapy
- (2020) Jonathan G. Pol et al. CYTOKINE & GROWTH FACTOR REVIEWS
- CAR T cells targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors
- (2019) Robbie G. Majzner et al. CLINICAL CANCER RESEARCH
- NK cells expressing a chimeric activating receptor eliminate MDSCs and rescue impaired CAR-T cell activity against solid tumors
- (2019) Robin Parihar et al. Cancer Immunology Research
- Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor–transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma
- (2019) Stephanie L. Goff et al. JOURNAL OF IMMUNOTHERAPY
- Antitumor Responses in the Absence of Toxicity in Solid Tumors by Targeting B7-H3 via Chimeric Antigen Receptor T Cells
- (2019) Hongwei Du et al. CANCER CELL
- Hypoxia Selectively Impairs CAR-T Cells In Vitro
- (2019) Robert Berahovich et al. Cancers
- Safety, tolerability, and pharmacokinetics of anti-EGFRvIII antibody–drug conjugate AMG 595 in patients with recurrent malignant glioma expressing EGFRvIII
- (2019) Mark Rosenthal et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma
- (2019) Cyril Neftel et al. CELL
- Phase I study of lentiviral-transduced chimeric antigen receptor modified T cells recognizing mesothelin in advanced solid cancers
- (2019) Andrew R. Haas et al. MOLECULAR THERAPY
- Meningeal lymphatic vessels at the skull base drain cerebrospinal fluid
- (2019) Ji Hoon Ahn et al. NATURE
- Circular ecDNA promotes accessible chromatin and high oncogene expression
- (2019) Sihan Wu et al. NATURE
- CXCR1- or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors
- (2019) Linchun Jin et al. Nature Communications
- CRISPR-Cas9 disruption of PD-1 enhances activity of universal EGFRvIII CAR T cells in a preclinical model of human glioblastoma
- (2019) Bryan D. Choi et al. Journal for ImmunoTherapy of Cancer
- Mouse Models for Immunotherapy in Hepatocellular Carcinoma
- (2019) Enya Li et al. Cancers
- Expression profiling of single cells and patient cohorts identifies multiple immunosuppressive pathways and an altered NK cell phenotype in glioblastoma
- (2019) H. J. Close et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Teaming up for CAR-T cell therapy
- (2019) Ralph Wäsch et al. HAEMATOLOGICA
- Nitinol thin films functionalized with CAR-T cells for the treatment of solid tumours
- (2019) Michael E. Coon et al. Nature Biomedical Engineering
- Hacking macrophage-associated immunosuppression for regulating glioblastoma angiogenesis
- (2018) Xin Cui et al. BIOMATERIALS
- T-cell Dysfunction in Glioblastoma: Applying a New Framework
- (2018) Karolina I. Woroniecka et al. CLINICAL CANCER RESEARCH
- New developments in immunotherapy for pediatric solid tumors
- (2018) Liora M. Schultz et al. CURRENT OPINION IN PEDIATRICS
- Activity of Mesothelin-Specific Chimeric Antigen Receptor T Cells Against Pancreatic Carcinoma Metastases in a Phase 1 Trial
- (2018) Gregory L. Beatty et al. GASTROENTEROLOGY
- Development of a new patient-derived xenograft humanised mouse model to study human-specific tumour microenvironment and immunotherapy
- (2018) Yue Zhao et al. GUT
- Preclinical Models in Chimeric Antigen Receptor–Engineered T-Cell Therapy
- (2018) Elizabeth Louise Siegler et al. HUMAN GENE THERAPY
- Discordant inheritance of chromosomal and extrachromosomal DNA elements contributes to dynamic disease evolution in glioblastoma
- (2018) Ana C. deCarvalho et al. NATURE GENETICS
- Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells
- (2018) Margherita Norelli et al. NATURE MEDICINE
- CAR T cell–induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade
- (2018) Theodoros Giavridis et al. NATURE MEDICINE
- CAR T-cell therapy for glioblastoma: recent clinical advances and future challenges
- (2018) Stephen J Bagley et al. NEURO-ONCOLOGY
- Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
- (2018) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Enhancing the Potency and Specificity of Engineered T Cells for Cancer Treatment
- (2018) Sujita Sukumaran et al. Cancer Discovery
- Temozolomide lymphodepletion enhances CAR abundance and correlates with antitumor efficacy against established glioblastoma
- (2018) Carter M. Suryadevara et al. OncoImmunology
- Functional aspects of meningeal lymphatics in ageing and Alzheimer’s disease
- (2018) Sandro Da Mesquita et al. NATURE
- Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumors
- (2018) Pakawat Chongsathidkiet et al. NATURE MEDICINE
- Checkpoint blockade reverses anergy in IL13Rα2 humanized scFv based CAR T cells to treat murine and canine gliomas.
- (2018) Yibo Yin et al. Molecular Therapy-Oncolytics
- ASBMT Consensus Grading for Cytokine Release Syndrome and Neurological Toxicity Associated with Immune Effector Cells
- (2018) Daniel W Lee et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Preventing Lck Activation in CAR T Cells Confers Treg Resistance but Requires 4-1BB Signaling for Them to Persist and Treat Solid Tumors in Nonlymphodepleted Hosts
- (2018) Carter M. Suryadevara et al. CLINICAL CANCER RESEARCH
- Chimeric Antigen Receptor–modified T Cells Repressed Solid Tumors and Their Relapse in an Established Patient-derived Colon Carcinoma Xenograft Model
- (2018) Ruidi Teng et al. JOURNAL OF IMMUNOTHERAPY
- Establishment of peripheral blood mononuclear cell-derived humanized lung cancer mouse models for studying efficacy of PD-L1/PD-1 targeted immunotherapy
- (2018) Shouheng Lin et al. mAbs
- TGF-β-associated extracellular matrix genes link cancer-associated fibroblasts to immune evasion and immunotherapy failure
- (2018) Ankur Chakravarthy et al. Nature Communications
- Mouse Models for Cancer Immunotherapy Research
- (2018) Brian Olson et al. Cancer Discovery
- Modeling anti-CD19 CAR T cell therapy in humanized mice with human immunity and autologous leukemia
- (2018) Chun-Hui Jin et al. EBioMedicine
- Targeting the adenosine 2A receptor enhances chimeric antigen receptor T cell efficacy
- (2017) Paul A. Beavis et al. JOURNAL OF CLINICAL INVESTIGATION
- Biopolymers codelivering engineered T cells and STING agonists can eliminate heterogeneous tumors
- (2017) Tyrel T. Smith et al. JOURNAL OF CLINICAL INVESTIGATION
- Phase I Escalating-Dose Trial of CAR-T Therapy Targeting CEA + Metastatic Colorectal Cancers
- (2017) Chengcheng Zhang et al. MOLECULAR THERAPY
- Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity
- (2017) Kristen M. Turner et al. NATURE
- Tumour-associated macrophages as treatment targets in oncology
- (2017) Alberto Mantovani et al. Nature Reviews Clinical Oncology
- A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
- (2017) Donald M. O’Rourke et al. Science Translational Medicine
- Combined antiangiogenic and anti–PD-L1 therapy stimulates tumor immunity through HEV formation
- (2017) Elizabeth Allen et al. Science Translational Medicine
- Reporter gene imaging of targeted T cell immunotherapy in recurrent glioma
- (2017) Khun Visith Keu et al. Science Translational Medicine
- Treatment of hepatocellular carcinoma with a GPC3-targeted bispecific T cell engager
- (2017) Yanyu Bi et al. Oncotarget
- An oxygen sensitive self-decision making engineered CAR T-cell
- (2017) Alexandre Juillerat et al. Scientific Reports
- Phase I study of chimeric antigen receptor modified T cells in treating HER2-positive advanced biliary tract cancers and pancreatic cancers
- (2017) Kaichao Feng et al. Protein & Cell
- Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancer
- (2017) Kristen M. Hege et al. Journal for ImmunoTherapy of Cancer
- Defining the optimal murine models to investigate immune checkpoint blockers and their combination with other immunotherapies
- (2016) M. F. Sanmamed et al. ANNALS OF ONCOLOGY
- L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity
- (2016) Roger Geiger et al. CELL
- Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells
- (2016) Omkar U. Kawalekar et al. IMMUNITY
- PD-1/PD-L1 blockade in cancer treatment: perspectives and issues
- (2016) Junzo Hamanishi et al. International Journal of Clinical Oncology
- Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition
- (2016) Leonid Cherkassky et al. JOURNAL OF CLINICAL INVESTIGATION
- Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
- (2016) Christine E. Brown et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chimeric antigen receptor-modified T cells for the treatment of solid tumors: Defining the challenges and next steps
- (2016) Gregory L. Beatty et al. PHARMACOLOGY & THERAPEUTICS
- Phase I Trial of Anti-PSMA Designer CAR-T Cells in Prostate Cancer: Possible Role for Interacting Interleukin 2-T Cell Pharmacodynamics as a Determinant of Clinical Response
- (2016) Richard P. Junghans et al. PROSTATE
- Chimeric antigen receptor T cells secreting anti-PD-L1 antibodies more effectively regress renal cell carcinoma in a humanized mouse model
- (2016) Eloah Rabello Suarez et al. Oncotarget
- Immunological Evasion in Glioblastoma
- (2016) Roxana Magaña-Maldonado et al. Biomed Research International
- Augmentation of CAR T-cell Trafficking and Antitumor Efficacy by Blocking Protein Kinase A Localization
- (2016) K. Newick et al. Cancer Immunology Research
- Patient-Specific Screening Using High-Grade Glioma Explants to Determine Potential Radiosensitization by a TGF-β Small Molecule Inhibitor
- (2016) N. Sumru Bayin et al. NEOPLASIA
- Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T
- (2015) Rachel A. Burga et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Phosphoenolpyruvate Is a Metabolic Checkpoint of Anti-tumor T Cell Responses
- (2015) Ping-Chih Ho et al. CELL
- Bioactivity and Safety of IL13R 2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
- (2015) C. E. Brown et al. CLINICAL CANCER RESEARCH
- Disialoganglioside GD2 as a therapeutic target for human diseases
- (2015) Maya Suzuki et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Human Epidermal Growth Factor Receptor 2 (HER2) –Specific Chimeric Antigen Receptor–Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma
- (2015) Nabil Ahmed et al. JOURNAL OF CLINICAL ONCOLOGY
- Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytes
- (2015) Ignazio Caruana et al. NATURE MEDICINE
- Rational development and characterization of humanized anti–EGFR variant III chimeric antigen receptor T cells for glioblastoma
- (2015) Laura A. Johnson et al. Science Translational Medicine
- Concise Review: Humanized Models of Tumor Immunology in the 21st Century: Convergence of Cancer Research and Tissue Engineering
- (2015) Boris Michael Holzapfel et al. STEM CELLS
- Immune Escape Mechanisms as a Guide for Cancer Immunotherapy
- (2014) G. L. Beatty et al. CLINICAL CANCER RESEARCH
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Reversal of Tumor Immune Inhibition Using a Chimeric Cytokine Receptor
- (2014) Ann M Leen et al. MOLECULAR THERAPY
- EGFRvIII-Specific Chimeric Antigen Receptor T Cells Migrate to and Kill Tumor Deposits Infiltrating the Brain Parenchyma in an Invasive Xenograft Model of Glioblastoma
- (2014) Hongsheng Miao et al. PLoS One
- Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
- (2014) A. P. Patel et al. SCIENCE
- Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity
- (2014) P. S. Adusumilli et al. Science Translational Medicine
- Extrachromosomal driver mutations in glioblastoma and low-grade glioma
- (2014) Sergey Nikolaev et al. Nature Communications
- Nutrient Sensing via mTOR in T Cells Maintains a Tolerogenic Microenvironment
- (2014) Duncan Howie et al. Frontiers in Immunology
- The potential impact of mouse model selection in preclinical evaluation of cancer immunotherapy
- (2014) Jennifer A Westwood et al. OncoImmunology
- CD44v6-targeted T cells mediate potent antitumor effects against acute myeloid leukemia and multiple myeloma
- (2013) M. Casucci et al. BLOOD
- Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis
- (2013) Chih-Hao Chang et al. CELL
- The Somatic Genomic Landscape of Glioblastoma
- (2013) Cameron W. Brennan et al. CELL
- EGFRvIII mCAR-Modified T-Cell Therapy Cures Mice with Established Intracerebral Glioma and Generates Host Immunity against Tumor-Antigen Loss
- (2013) J. H. Sampson et al. CLINICAL CANCER RESEARCH
- HER2-positive gastric cancer
- (2013) Narikazu Boku Gastric Cancer
- Of CARs and TRUCKs: chimeric antigen receptor (CAR) T cells engineered with an inducible cytokine to modulate the tumor stroma
- (2013) Markus Chmielewski et al. IMMUNOLOGICAL REVIEWS
- TGF- : Guardian of T Cell Function
- (2013) S. A. Oh et al. JOURNAL OF IMMUNOLOGY
- Preclinical In Vivo Modeling of Cytokine Release Syndrome Induced by ErbB-Retargeted Human T Cells: Identifying a Window of Therapeutic Opportunity?
- (2013) S. J. C. van der Stegen et al. JOURNAL OF IMMUNOLOGY
- Antitumor Effects of Chimeric Receptor Engineered Human T Cells Directed to Tumor Stroma
- (2013) Sunitha Kakarla et al. MOLECULAR THERAPY
- Microenvironmental regulation of tumor progression and metastasis
- (2013) Daniela F Quail et al. NATURE MEDICINE
- CD19 CAR-Targeted T Cells Induce Long-Term Remission and B Cell Aplasia in an Immunocompetent Mouse Model of B Cell Acute Lymphoblastic Leukemia
- (2013) Marco L. Davila et al. PLoS One
- Targeted Therapy Resistance Mediated by Dynamic Regulation of Extrachromosomal Mutant EGFR DNA
- (2013) David A. Nathanson et al. SCIENCE
- Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicity
- (2013) L.-C. S. Wang et al. Cancer Immunology Research
- Resistance of Glioblastoma-Initiating Cells to Radiation Mediated by the Tumor Microenvironment Can Be Abolished by Inhibiting Transforming Growth Factor-β
- (2012) Matthew E. Hardee et al. CANCER RESEARCH
- Modulation of Microenvironment Acidity Reverses Anergy in Human and Murine Tumor-Infiltrating T Lymphocytes
- (2012) A. Calcinotto et al. CANCER RESEARCH
- The Promise of Patient-Derived Xenografts: The Best Laid Plans of Mice and Men
- (2012) S. Kopetz et al. CLINICAL CANCER RESEARCH
- Xenogeneic Graft-versus-Host-Disease in NOD-scid IL-2Rγnull Mice Display a T-Effector Memory Phenotype
- (2012) Niwa Ali et al. PLoS One
- Development of human CD4+FoxP3+ regulatory T cells in human stem cell factor-, granulocyte-macrophage colony-stimulating factor-, and interleukin-3-expressing NOD-SCID IL2R null humanized mice
- (2011) E. Billerbeck et al. BLOOD
- Mosaic Amplification of Multiple Receptor Tyrosine Kinase Genes in Glioblastoma
- (2011) Matija Snuderl et al. CANCER CELL
- TGF- downregulates the activating receptor NKG2D on NK cells and CD8+ T cells in glioma patients
- (2011) C. A. Crane et al. NEURO-ONCOLOGY
- Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
- (2010) Roel G.W. Verhaak et al. CANCER CELL
- Selective Expansion of Chimeric Antigen Receptor-targeted T-cells with Potent Effector Function using Interleukin-4
- (2010) Scott Wilkie et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Gene therapy using genetically modified lymphocytes targeting VEGFR-2 inhibits the growth of vascularized syngenic tumors in mice
- (2010) Dhanalakshmi Chinnasamy et al. JOURNAL OF CLINICAL INVESTIGATION
- Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
- (2010) Richard A Morgan et al. MOLECULAR THERAPY
- Chemokine Expression in Melanoma Metastases Associated with CD8+ T-Cell Recruitment
- (2009) H. Harlin et al. CANCER RESEARCH
- A meta-analysis on the association of HER-2 overexpression with prognosis in human osteosarcoma
- (2009) Y.G. LI et al. EUROPEAN JOURNAL OF CANCER CARE
- Immunotherapy for Osteosarcoma: Genetic Modification of T cells Overcomes Low Levels of Tumor Antigen Expression
- (2009) Nabil Ahmed et al. MOLECULAR THERAPY
- Therapeutic Targets in Malignant Glioblastoma Microenvironment
- (2009) Mary Helen Barcellos-Hoff et al. SEMINARS IN RADIATION ONCOLOGY
- Transforming Growth Factor- Receptor Blockade Augments the Effectiveness of Adoptive T-Cell Therapy of Established Solid Cancers
- (2008) A. Wallace et al. CLINICAL CANCER RESEARCH
- Mechanisms of regulatory T-cell suppression – a diverse arsenal for a moving target
- (2008) Dorothy K. Sojka et al. IMMUNOLOGY
- Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma
- (2008) John H. Sampson et al. SEMINARS IN IMMUNOLOGY
- NKG2D ligands: key targets of the immune response
- (2008) Segundo González et al. TRENDS IN IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now